ALT FY 2013 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena

ALTAltimmune, Inc.

$335M

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$18M-28.9% YoY

Gross Profit

$18M100.0% margin

Operating Income

-$11M-60.5% margin

Net Income

-$12M-65.4% margin

EPS (Diluted)

$-69.40

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$17M

Total Liabilities

$10M

Stockholders' Equity

$7M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$25M	-28.9%
Gross Profit	$18M	$25M	-28.9%
Operating Income	-$11M	-$6M	-73.0%
Net Income	-$12M	-$5M	-138.2%